Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLLchronic lymphocytic leukemia/small lymphocytic lymphomaRecruitingPhase 1 / Phase 22026-10-05NCT05791409

4 results · Page 1 of 1

29 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AU-Melbourne-ALFREDMelbourneAustralia4
AU-Melbourne-MONASHMelbourneAustralia5
AU-Melbourne-SVHMMelbourneAustralia3
BE-Antwerpen-ZNASTUIVENBERGAntwerpBelgium8
BE-Roeselare-AZDELTARoeselareBelgium7
DE-Berlin-HELIOSBERLINBUCHBerlinGermany1
DE-Freiburg-UNIKLINIKFREIBURGFreiburg im BreisgauGermany3
DE-Greifswald-UNIGREIFSWALDGreifswaldGermany5
DE-Halle-UMHHalleGermany3
DE-Kiel-UKSHKielGermany1
DE-Köln-UKKOELNCologneGermany1
DE-Munster-GEMEINSCHAFTSPRAXISMünsterGermany1
DE-Stuttgart-RBKStuttgartGermany1
DE-Ulm-UNIKLINKULMUlmGermany6
DK-Aalborg-ALBOGUHAalborgDenmark1
DK-Copenhagen-RigshospitaletCopenhagenDenmark5
DK-Odense-OUHOdenseDenmark5
NL-Alkmaar-NWZAlkmaarNetherlands1
NL-Amersfoort-MEANDERMCAmersfoortNetherlands13
NL-Amsterdam-AMCAmsterdamNetherlands10
NL-Den Bosch-JBZ's-HertogenboschNetherlands14
NL-Den Haag-HAGAThe HagueNetherlands13
NL-Dordrecht-ASZDordrechtNetherlands14
NL-Ede-ZGVEdeNetherlands6
NL-Eindhoven-CATHARINAEindhovenNetherlands7